Skip to main content
Equibles

PNC FINANCIAL SERVICES GROUP, INC.

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 713676 Pittsburgh, PA
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$8,106
+$1,085 QoQ
Shares Held
556
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,432,736 across 262 Biotechnology names. ENTA ranks #152 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 69,358 $34,452,195
2 REGN
Regeneron Pharmaceuticals, Inc.
 16,662 $10,389,420
3 TECH
BIO-TECHNE Corp
 77,074 $5,445,277
4 MRNA
Moderna, Inc.
 70,829 $4,960,151
5 TGTX
Tg Therapeutics, Inc.
 89,646 $4,925,149
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 39,473 $3,847,827
7 INCY
Incyte Corp
 32,777 $3,715,597
8 ARGX
Argenx SE
 3,967 $3,680,460

All Filings in ENTA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,106 556
2026-03-31 $7,021 556
2025-12-31 $12,393 786
2025-09-30 $9,550 798
2025-06-30 $5,072 671
2025-03-31 $2,064 374
2024-12-31 $460 80
2024-09-30 $3,304 319
2024-06-30 $4,137 319
2024-03-31 $37,573 2,152
2023-12-31 $2,013 214
2023-09-30 $11,648 1,043
2023-06-30 $59,297 2,771
2023-03-31 $45,413 1,123
2022-12-31 $48,983 1,053
2022-09-30 $54,824 1,057
2022-06-30 $24,721 523
2022-03-31 $81,143 1,140
2021-12-31 $83,229 1,113
2021-09-30 $54,536 960
2021-06-30 $70,459 1,601
2021-03-31 $38,814 787
2020-12-31 $23,195 551
2020-09-30 $49,624 1,084
2020-06-30 $53,773 1,071
2020-03-31 $54,924 1,068